Trial Profile
Imaging Brain Tumors With FACBC and Methionine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluciclovine 18F (Primary) ; Methionine (Primary)
- Indications Brain cancer; Tumours
- Focus Diagnostic use
- 02 Dec 2019 Status changed from active, no longer recruiting to completed.
- 03 Jun 2019 Planned End Date changed from 1 May 2019 to 1 May 2020.
- 03 Jun 2019 Planned primary completion date changed from 1 May 2019 to 1 May 2020.